麒盛科技(603610.SH):擬投資約11.4億元建設智能牀配套數字化電器系統生產項目
格隆匯4月2日丨麒盛科技(603610.SH)公佈,2024年4月2日,公司第三屆董事會第十四次會議審議通過了《關於公司簽訂<項目投資協議>的議案》,同意公司與嘉興市秀洲區王江涇鎮人民政府簽署《項目投資協議》。本項目主要產品為智能電動牀電器系統(以下簡稱“電器系統”)及智能牀配套靠背及縫紉外套,其中電器系統包括調節系統、智能控制系統、多功能操作系統及睡眠管理智能系統。該項目建成後,可形成調節系統產能800萬套/年,控制系統產能400萬套/年,操作系統產能400萬套/年,睡眠管理智能系統100萬套/年,縫紉外套100萬張/年,智能牀配套靠背產能50萬張/年的生產。項目總投資約11.4億元。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.